According to a CB Insight's report, GV (formerly Google Ventures) funded the most digital health companies with 22 investments, making it most active investor in that sector for four years in a row.
The lead drug candidate of Imara failed two separate mid-stage clinical trials evaluating it in rare, inherited hemoglobin disorders. Imara had been planning to advance the small molecule to yet another Phase 2 study in heart failure, but in light of the twin trial failures, the biotech is now weighing "strategic options."
Preventia and LifeOmic partnered to create the free LIFE Extend app to serve mental health needs of Butler University students. It not only connects them to online therapists, but also helps students track their sleep, exercise, nutrition, and mindfulness.
Evozyne uses artificial intelligence and machine learning to design novel proteins that can be used in gene therapies. The new agreement with Takeda Pharmaceutical covers the development of proteins that can be used in gene therapies for rare diseases.
Galileo Health now offers around the clock medical care in Spanish to the insured and uninsured alike, hoping to reach underprivileged and minority patients, especially the 53 million Spanish-speaking people in America.
By Harsha Rajasimha Tuesday, April 5, 2022 9:00 AM
Informed consent isn't as simple as getting verbal or written consent from a participant one time. Rather, it is the start of an ongoing relationship based on communication.
No comments